Home > Qtrly Results > SUN PHARMACEUTICAL INDUSTRIES

SUN PHARMACEUTICAL INDUSTRIES
Quarterly Results Analysis [Jun2025]

SUN PHARMACEUTICAL INDUSTRIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for SUN PHARMACEUTICAL INDUSTRIES
Please provide your vote to see the results

SUN PHARMACEUTICAL INDUSTRIES Quarterly Results

Consolidated Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Revenues ₹13,851 Cr ₹12,959 Cr ₹13,675 Cr ₹13,291 Cr ₹12,653 Cr ₹11,983 Cr ₹12,381 Cr ₹12,192 Cr
Expenses ₹9,779 Cr ₹9,534 Cr ₹9,666 Cr ₹9,481 Cr ₹9,045 Cr ₹8,948 Cr ₹9,028 Cr ₹9,013 Cr
Operating Income ₹4,073 Cr ₹3,425 Cr ₹4,009 Cr ₹3,811 Cr ₹3,608 Cr ₹3,035 Cr ₹3,352 Cr ₹3,179 Cr
Other Income ₹694 Cr ₹904 Cr ₹466 Cr ₹482 Cr ₹533 Cr ₹606 Cr ₹375 Cr ₹294 Cr
Interest ₹75 Cr ₹49 Cr ₹52 Cr ₹69 Cr ₹62 Cr ₹74 Cr ₹35 Cr ₹49 Cr
Depreciation ₹701 Cr ₹664 Cr ₹631 Cr ₹626 Cr ₹655 Cr ₹650 Cr ₹622 Cr ₹633 Cr
Profit Before Tax ₹3,173 Cr ₹3,254 Cr ₹3,476 Cr ₹3,598 Cr ₹3,424 Cr ₹2,816 Cr ₹3,000 Cr ₹2,791 Cr
Profit After Tax ₹2,303 Cr ₹2,161 Cr ₹2,918 Cr ₹3,031 Cr ₹2,871 Cr ₹2,667 Cr ₹2,568 Cr ₹2,401 Cr
EPS ₹9.50 ₹8.96 ₹12.10 ₹12.67 ₹11.82 ₹11.06 ₹10.52 ₹9.90
Industry Peers & Returns1W1M1Y
SUN PHARMACEUTICAL INDUSTRIES 3.4% 1.3% -11.6%
DIVIS LABORATORIES 2.4% 3.2% 11.9%
CIPLA 1.8% 1.9% -5.6%
TORRENT PHARMACEUTICALS 2.8% -0.9% 3.3%
DR REDDYS LABORATORIES 1.7% 6.2% -0.3%
MANKIND PHARMA 3% 6.2% 7.5%
ZYDUS LIFESCIENCES 0% 5.5% -5.6%
LUPIN 0.5% 6% -9.9%
AUROBINDO PHARMA 1.8% 6.9% -27.3%

SUN PHARMACEUTICAL INDUSTRIES Quarterly Revenues

Revenues
Q-o-Q

6.89 %

Y-o-Y

9.47 %

Quarters Revenues % Change
Jun2025 ₹13,851 Cr
6.89
Mar2025 ₹12,959 Cr
-5.24
Dec2024 ₹13,675 Cr
2.89
Sep2024 ₹13,291 Cr
5.05
Jun2024 ₹12,653 Cr
5.59
Mar2024 ₹11,983 Cr
-3.21
Dec2023 ₹12,381 Cr
1.54
Sep2023 ₹12,192 Cr -

SUN PHARMACEUTICAL INDUSTRIES Quarterly Operating Profit

Operating Profit
Q-o-Q

18.91 %

Y-o-Y

12.89 %

Quarters Operating Profit % Change
Jun2025 ₹4,073 Cr
18.91
Mar2025 ₹3,425 Cr
-14.57
Dec2024 ₹4,009 Cr
5.20
Sep2024 ₹3,811 Cr
5.63
Jun2024 ₹3,608 Cr
18.86
Mar2024 ₹3,035 Cr
-9.46
Dec2023 ₹3,352 Cr
5.44
Sep2023 ₹3,179 Cr -
Operating Margins
Q-o-Q

11.24 %

Y-o-Y

3.12 %

Quarters Operating Margin% % Change
Jun2025 29.4%
11.24
Mar2025 26.43%
-9.86
Dec2024 29.32%
2.27
Sep2024 28.67%
0.56
Jun2024 28.51%
12.55
Mar2024 25.33%
-6.46
Dec2023 27.08%
3.83
Sep2023 26.08% -

SUN PHARMACEUTICAL INDUSTRIES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

6.57 %

Y-o-Y

-19.80 %

Quarters Profit After Tax % Change
Jun2025 ₹2,303 Cr
6.57
Mar2025 ₹2,161 Cr
-25.94
Dec2024 ₹2,918 Cr
-3.73
Sep2024 ₹3,031 Cr
5.55
Jun2024 ₹2,871 Cr
7.67
Mar2024 ₹2,667 Cr
3.84
Dec2023 ₹2,568 Cr
6.97
Sep2023 ₹2,401 Cr -
PAT Margins
Q-o-Q

-0.30 %

Y-o-Y

-26.75 %

Quarters PAT Margin(%) % Change
Jun2025 16.62 %
-0.30
Mar2025 16.67 %
-21.85
Dec2024 21.33 %
-6.45
Sep2024 22.8 %
0.48
Jun2024 22.69 %
1.98
Mar2024 22.25 %
7.28
Dec2023 20.74 %
5.33
Sep2023 19.69 % -

SUN PHARMACEUTICAL INDUSTRIES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

6.03 %

Y-o-Y

-19.63 %

Quarters EPS % Change
Jun2025 ₹9.5
6.03
Mar2025 ₹8.96
-25.95
Dec2024 ₹12.1
-4.50
Sep2024 ₹12.67
7.19
Jun2024 ₹11.82
6.87
Mar2024 ₹11.06
5.13
Dec2023 ₹10.52
6.26
Sep2023 ₹9.9 -

You may also like the below Video Courses